Geneos Wealth Management Inc. - BIOLINERX LTD ownership

Quarter-by-quarter ownership
Geneos Wealth Management Inc. ownership history of BIOLINERX LTD
ValueSharesWeighting
Q3 2023$73,710
+96.0%
40,500
+72.3%
0.00%
+100.0%
Q2 2023$37,600
+79.8%
23,5000.0%0.00%
+100.0%
Q1 2023$20,915
+50.8%
23,5000.0%0.00%0.0%
Q4 2022$13,865
-34.0%
23,5000.0%0.00%0.0%
Q3 2022$21,000
-60.4%
23,500
-43.3%
0.00%
-66.7%
Q2 2022$53,000
-5.4%
41,450
+25.8%
0.00%
+50.0%
Q1 2022$56,000
-5.1%
32,950
+13.8%
0.00%0.0%
Q4 2021$59,000
+20.4%
28,950
+63.1%
0.00%0.0%
Q3 2021$49,000
-15.5%
17,750
+1.7%
0.00%0.0%
Q2 2021$58,00017,4500.00%
Other shareholders
BIOLINERX LTD shareholders Q4 2023
NameSharesValueWeighting ↓
PVG ASSET MANAGEMENT CORP 76,510$210,402,0000.63%
Parkman Healthcare Partners LLC 411,060$1,130,0000.29%
Game Plan Financial Advisors, LLC 25,000$69,0000.04%
ACT CAPITAL MANAGEMENT, LLC 27,500$76,0000.04%
Intellectus Partners, LLC 28,500$78,0000.02%
Cutter & CO Brokerage, Inc. 18,667$51,0000.01%
Opaleye Management Inc. 16,667$46,0000.01%
ARK Investment Management 1,073,913$2,953,0000.01%
First Heartland Consultants, Inc. 10,000$27,0000.00%
Thomasville National Bank 10,000$28,0000.00%
View complete list of BIOLINERX LTD shareholders